BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Bleomycin
,
rs6983267
,
FXYD4
,
G-protein-coupled receptor binding
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myeloid leukaemias
Summary
General Info
Curated Studies
Most Correlated Studies
Comparison bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia (AML)
Transient myeloproliferative disorder (TMD) + acute megakaryoblastic leukaemia (AMKL) in DS patients
Stem and progenitor cells from acute, blastic, and chronic phase chronic myeloid leukemia patients
Bone marrow cells from MLL-AF9 transformed or normal non-transformed mice
MLL-AF9 transforms committted progenitors to leukemia stem cells
Explore Curated Studies Results
Literature
Most Relevant Literature
SOHO State of the Art Updates and Next Questions: Oral Therapy in Acute Myeloid Leukemia.
Assessing eligibility for treatment in acute myeloid leukemia in 2023.
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia.
Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with v…
How I treat refractory and relapsed acute myeloid leukemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in …
Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)
De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ